180 Wealth Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History
180 Wealth Advisors, LLC
- $629 Million
- Q3 2024
A detailed history of 180 Wealth Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 25,775 shares of RXRX stock, worth $164,960. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,775
Previous 17,455
47.67%
Holding current value
$164,960
Previous $130,000
30.0%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
289Shares Held
241MCall Options Held
984KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$210 Million2.05% of portfolio
-
Baillie Gifford & CO26.6MShares$170 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$111 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$98.5 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.16B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...